Bjarred
Sweden
8
2017-05-04
8
2018-09-25
These are the the leading inventors for applications assigned to Xintela AB:
Xintela AB based in Bjarred, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Integrin heterodimer and a subunit thereof
#2 | 2014-04-10 β Patent 9,365,649 granted on 2016-06-14Monoclonal antibody capable of binding integrin alpha 10 beta 1
#3 | 2013-05-30 β Patent 8,895,253 granted on 2014-11-25Integrin heterodimer and a subunit thereof
#4 | 2012-02-09 β Patent 8,563,255 granted on 2013-10-22Monoclonal antibody capable of binding integrin alpha 10 beta 1
#5 | 2011-02-10 β Patent 8,105,791 granted on 2012-01-31Marker for stem cells and its use
#6 | 2009-07-23 β Patent 8,012,696 granted on 2011-09-06Monoclonal antibody capable of binding integrin alpha 10 beta 1
#7 | 2006-08-10 β Patent 8,048,991 granted on 2011-11-01Antibody to an integrin heterodimer and/or a subunit thereof
#8 | 2005-10-06 β Patent 7,749,710 granted on 2010-07-06Marker for stem cells and its use
Also check out Xintela AB's (Bjarred, Sweden) applicant profile with 3 patent applications submitted.
61001 β